Improved Potency of Indole-Based NorA Efflux Pump Inhibitors: From Serendipity toward Rational Design and Development

Area of Science:

• Medicinal Chemistry
• Microbiology
• Drug Discovery

Background:

• The NorA efflux pump contributes to bacterial multidrug resistance.
• Developing inhibitors for the NorA efflux pump is crucial for combating antibiotic resistance.
• Previous research identified indole-based inhibitor candidates for the NorA efflux pump.

Purpose of the Study:

• To report a new class of NorA efflux pump inhibitors.
• To evaluate the potency of novel indole-based compounds against the NorA efflux pump.
• To explore structural modifications of existing inhibitors for improved efficacy.

Main Methods:

• Synthesis of a second class of indole-based compounds.
• In vitro evaluation of inhibitor potency using IC50 values.
• Comparison of newly synthesized compounds with previously identified indole-based inhibitors.

Main Results:

• Compounds 13 and 14 exhibited potent inhibition of the NorA efflux pump.
• The lowest IC50 values (2 μM) were recorded for compounds 13 and 14 among all evaluated indole-based compounds.
• The new inhibitors possess distinct shapes and sizes compared to earlier candidates.

Conclusions:

• Novel indole-based compounds are potent inhibitors of the NorA efflux pump.
• These findings offer promising leads for developing agents to overcome antibiotic resistance.
• Further investigation into these compounds could lead to new antibacterial therapies.